These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6289576)
1. Action of a calcium blocking agent (D600) on electrogenesis in the normal heart and the ischaemic heart in the dog. Van Bogaert A; De Schepper J Acta Cardiol; 1982; 37(3):183-97. PubMed ID: 6289576 [No Abstract] [Full Text] [Related]
2. Interval- and voltage-dependent effects of the calcium channel-blocking agents D600 and AQA 39 on mammalian ventricular muscle. Trautwein W; Pelzer D; McDonald TF Circ Res; 1983 Feb; 52(2 Pt 2):I60-8. PubMed ID: 6299606 [TBL] [Abstract][Full Text] [Related]
3. [Changes of action potential in human papillary muscles by methoxyverapamil (author's transl)]. Zong XG Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):108-12. PubMed ID: 6287802 [No Abstract] [Full Text] [Related]
4. On the mechanism of slow calcium channel block in heart. McDonald TF; Pelzer D; Trautwein W Pflugers Arch; 1980 May; 385(2):175-9. PubMed ID: 6248838 [TBL] [Abstract][Full Text] [Related]
5. Differentiation of calcium ion antagonism and beta-adrenergic blockade. Schlepper M Clin Invest Med; 1980; 3(1-2):9-12. PubMed ID: 6110500 [No Abstract] [Full Text] [Related]
6. Effect of D600, practolol, and alterations in magnesium on ionized calcium concentration-response relationships in the intact dog heart. Bristow MR; Daniels JR; Kernoff RS; Harrison DC Circ Res; 1977 Oct; 41(4):574-81. PubMed ID: 902364 [No Abstract] [Full Text] [Related]
7. [Effect of calcium antagonists on action potentials of muscle fibers in the warm-blooded]. Kafengauz BIu; Poskonova MA; Chudakov LI Biull Eksp Biol Med; 1981 Nov; 92(11):517-20. PubMed ID: 7317619 [TBL] [Abstract][Full Text] [Related]
8. Calcium channel block and recovery from block in mammalian ventricular muscle treated with organic channel inhibitors. Pelzer D; Trautwein W; McDonald TF Pflugers Arch; 1982 Aug; 394(2):97-105. PubMed ID: 6289260 [No Abstract] [Full Text] [Related]
9. Comparative effects of gallopamil and verapamil on the mechanical and electrophysiological parameters of isolated guinea-pig myocardium. Noguchi K; Masumiya H; Takahashi K; Kaneko K; Higuchi S; Tanaka H; Shigenobu K Can J Physiol Pharmacol; 1997 Dec; 75(12):1316-21. PubMed ID: 9534940 [TBL] [Abstract][Full Text] [Related]
10. Effects of the novel calcium channel blocker, anipamil, on the isolated rabbit heart. Comparison with verapamil and gallopamil. Raddino R; Poli E; Pasini E; Ferrari R Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):339-44. PubMed ID: 1383837 [TBL] [Abstract][Full Text] [Related]
11. Cardioselective effects of gallopamil compared with verapamil in the dog heart. Takahashi K; Tsuchida K; Aihara H Arch Int Pharmacodyn Ther; 1988; 295():157-73. PubMed ID: 3245731 [TBL] [Abstract][Full Text] [Related]
12. Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane? Hescheler J; Pelzer D; Trube G; Trautwein W Pflugers Arch; 1982 Jun; 393(4):287-91. PubMed ID: 6289248 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of calcium channels in neuroblastoma x glioma hybrid cells by verapamil, D600, diltiazem and nisoldipine. Bodewei R; Hering S; Schubert B; Wollenberger A Biomed Biochim Acta; 1987; 46(8-9):S688-90. PubMed ID: 2449201 [TBL] [Abstract][Full Text] [Related]
15. D600 as a direct blocker of Ca-dependent K currents in Helix neurons. Gola M; Ducreux C Eur J Pharmacol; 1985 Nov; 117(3):311-22. PubMed ID: 2416577 [TBL] [Abstract][Full Text] [Related]
16. Blocking of frog endplate channels by the organic calcium antagonist D600. Bregestovski PD; Miledi R; Parker I Proc R Soc Lond B Biol Sci; 1980 Dec; 211(1182):15-24. PubMed ID: 6111072 [No Abstract] [Full Text] [Related]
17. Influence of Ca++-channel blocking agents on calcium transients and tension development in isolated mammalian heart muscle. Morgan JP; Wier WG; Hess P; Blinks JR Circ Res; 1983 Feb; 52(2 Pt 2):I47-52. PubMed ID: 6831653 [TBL] [Abstract][Full Text] [Related]
18. Calcium channel blockers: rationale for their clinical use. Conti CR J Fla Med Assoc; 1981 Nov; 68(11):883-6. PubMed ID: 6120992 [No Abstract] [Full Text] [Related]
19. [Calcium antagonists: sites of action, pharmacological effect profile and clinical use. 1: Physiologic significance of calcium ions and mechanisms of action of calcium antagonists in the subcellular area]. Bluth R; Langnickel R Z Arztl Fortbild (Jena); 1986; 80(5):191-7. PubMed ID: 2424181 [No Abstract] [Full Text] [Related]